rdf:type |
|
lifeskim:mentions |
umls-concept:C0000578,
umls-concept:C0001962,
umls-concept:C0009830,
umls-concept:C0021469,
umls-concept:C0034693,
umls-concept:C0034721,
umls-concept:C0205099,
umls-concept:C0205100,
umls-concept:C0441472,
umls-concept:C0449432,
umls-concept:C1179435,
umls-concept:C1524073,
umls-concept:C1548799,
umls-concept:C1705248
|
pubmed:issue |
3
|
pubmed:dateCreated |
1994-7-11
|
pubmed:abstractText |
When administered under a backward conditioning paradigm, 5-HTP administration resulted in a decrease in ethanol intake followed by a persistently decreased ethanol consumption. A central component to this inhibitory effect was suggested by the inability of xylamidine to significantly reduce the initial inhibitory effect of 5-HTP. The persistent rejection was prevented by xylamidine. Methysergide reduced the initial as well as the persistent effects of 5-HTP. In studies utilizing a forward conditioning paradigm, 5-HTP and lithium were each effective in developing CTAs to ethanol and saccharin. Only the ethanol-5-HTP pairing showed a persistent aversion. A peripheral component to the actions of 5-HTP was suggested by xylamidine blocking the CTAs induced by 5-HTP. Xylamidine also prevented the persistent ethanol avoidance induced by 5-HTP, but was ineffective in antagonizing lithium-induced CTAs. These results suggest central as well as peripheral components associated with the inhibitory effects of 5-HTP on ethanol consumption. Central actions appear to mediate the initial inhibitory effects while peripheral actions appear to be associated with persistent avoidance of ethanol following 5-HTP treatment.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0091-3057
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
47
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
547-51
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8208773-5-Hydroxytryptophan,
pubmed-meshheading:8208773-Alcohol Drinking,
pubmed-meshheading:8208773-Amidines,
pubmed-meshheading:8208773-Animals,
pubmed-meshheading:8208773-Central Nervous System,
pubmed-meshheading:8208773-Conditioning, Operant,
pubmed-meshheading:8208773-Depression, Chemical,
pubmed-meshheading:8208773-Lithium,
pubmed-meshheading:8208773-Male,
pubmed-meshheading:8208773-Methysergide,
pubmed-meshheading:8208773-Peripheral Nervous System,
pubmed-meshheading:8208773-Rats,
pubmed-meshheading:8208773-Rats, Sprague-Dawley,
pubmed-meshheading:8208773-Saccharin,
pubmed-meshheading:8208773-Serotonin,
pubmed-meshheading:8208773-Serotonin Antagonists,
pubmed-meshheading:8208773-Taste
|
pubmed:year |
1994
|
pubmed:articleTitle |
Central and peripheral components of the inhibitory actions of 5-HTP on ethanol consumption in the rat.
|
pubmed:affiliation |
Department of Pharmacology and Toxicology, School of Pharmacy and Pharmacal Sciences, Purdue University, West Lafayette, IN 47907-1334.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|